¼¼°èÀÇ ELISA ºÐ¼®±â ½ÃÀå-»ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, °æÀï, ±âȸ, ¿¹Ãø(2018-2028³â)
ELISA Analyzers Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028F Segmented By Type, By Mode, By Application, By End user, By Region and Competition
»óǰÄÚµå : 1309866
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2023³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 117 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,151,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,519,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 10,936,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ELISA ºÐ¼®±â(ELISA Analyzers) ½ÃÀåÀº 2024³âºÎÅÍ 2028³â±îÁö ¿¹Ãø ±â°£ µ¿¾È ´«ºÎ½Ã°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

À̰ÍÀº °¨¿° À¯ÇàÀ» Áø´ÜÇϱâ À§ÇÑ È¿À²ÀûÀÎ °Ë»ç ¼ö¿ä Áõ°¡³ª Áúº´ °ËÃâÀ» À§ÇÑ ±â¼úÀûÀ¸·Î °íµµ ±â±â ¿ä±¸ Áõ°¡ µîÀÌ ¿äÀÎÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°¨¿°Áõ À¯º´·ü »ó½Â

Àα¸°£¿¡ °¨¿° À¯ÇàÀÌ È®´ëµÇ°í ÀÖ´Â °ÍÀÌ ELISA ºÐ¼®±â ½ÃÀå ¼ö¿ä¸¦ ²ø¾î¿Ã¸®°í ÀÖ½À´Ï´Ù. Àü¿°º´ À¯ÇàÀº ¼¼°èÀûÀ¸·Î È®´ëµÇ°í ÀÖÀ¸¸ç ¼¼°è »ç¶÷µé¿¡°Ô Å« °Ç°­ ¹®Á¦¸¦ ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ¾Ï, °£¿°, HIV µî °¨¿° ÀÌ·¯ÇÑ ±Þ°ÝÇÑ Áõ°¡·Î Áø´Ü Á÷Á¢ÀûÀÎ ¼ö¿ä°¡ ±ÞÁõÇÏ°í ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î Àεµ¿¡ º»»ç¸¦ µÎ°í ÀÖ´Â Á¦¾àȸ»ç BioconÀº 2020³â ÅõÀÚ¸¦ ´Ã¸®°í 5,879¸¸ ´Þ·¯¸¦ ÁöÃâÇß½À´Ï´Ù.

¸é¿ª ºÐ¾ß ÃÖ÷´Ü ±â¼ú ¼ö¿ä Áõ°¡

¸é¿ªÇÐÀû °Ë»ç °á°ú ºÐ¼®¿¡´Â »ýÈ­ÇÐÀû ¹× ¸é¿ªÇÐÀû ÆÄ¶ó¹ÌÅÍ À¯Áö Á¤È®¼º°ú ½Å¼ÓÇÑ ºÐ¼®ÀÌ Áß¿ä ¿ä°ÇÀÔ´Ï´Ù. ºÐ¼®±â´Â °¨µµ À¯Áö, ¹è°æ ¼ÒÀ½ °¨¼Ò, ½Å¼ÓÇÑ ÀçÇö¼º µî ºÐ¼®ÀÇ ÀÌ»óÀûÀÎ ¼º´ÉÀ» º¸ÀåÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ¿ÀÇ ½Ã½ºÅÛ ÀÚµ¿ ºÐ¼® ÀåÄ¡¿Í °°Àº ELISA ºÐ¼® ÀåÄ¡¿¡´Â »çÀü ÇÁ·Î±×·¡¹ÖµÈ °Ë»ç ¸Þ´º¿Í °£´ÜÇÑ °¡À̵尡 ÀåÂøµÇ¾î ÀÖ¾î »ç¿ëÀÚ ÆíÀǼºÀ» Á¦°øÇÔ°ú µ¿½Ã¿¡ ¼³Ä¡ ½Ã°£À» Àý¾àÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 5¿ù °í¼º´É »ý¸í°úÇÐ ¼Ö·ç¼Ç ¼±µÎ ¾÷üÀÎ Molecular Devices, LLC.´Â ELISA ¿öÅ©Ç÷οì¿ë ÀÚµ¿ ¿öÅ©¼¿À» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ È¸»ç´Â È¿¼Ò °áÇÕ ¸é¿ªÈíÂø ÃøÁ¤¹ý(ELISA) ¿öÅ©Ç÷ο츦 À§ÇÑ 5°¡Áö ·¹À̵ð¸ÞÀÌµå ½Å±Ô ¿öÅ©¼¿À» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ¿öÅ©¼¿Àº ¿öÅ©¿þÀÌ ½Ã°£ ¹× 󸮷® Çâ»ó°ú °°Àº ÀÚµ¿È­ ǰÁúÀ» Á¦°øÇÏ¿© ´ë±Ô¸ð »ùÇà ³ëµ¿ Áý¾àÀûÀÎ ¹Ýº¹ ÀÛ¾÷À» ¿ÏÈ­ÇÕ´Ï´Ù.

È¿¼Ò Ȱ¼º ÃøÁ¤ ¼ö¿ä Áõ°¡

È¿¼Ò Ȱ¼º ÃøÁ¤Àº °¡¿ë¼º ´Ü¹éÁú, »çÀÌÅäÄ«ÀÎ ¹× ±âŸ ´Ü¹éÁúü °ËÃâ°ú ´õºÒ¾î ELISA ºÐ¼®±â ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾Ë·¹¸£±â Áõ·Ê°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ ELISA µî Áø´Ü ±â¼ú ¼ö¿ä·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ELISA´Â ½Äǰ ¾Ë·¹¸£±â °ËÃâ¿¡ ³Î¸® »ç¿ëµÇ´Â Áø´Ü ±â¼úÀÔ´Ï´Ù. °Ô´Ù°¡ °£Á¢ IgE-ELISA ¹æ¹ýÀºº° ÀÚµ¿È­ ½Ã½ºÅÛ¿¡ ºñÇØ °£ÆíÇϰí Àúºñ¿ëÀ̱⠶§¹®¿¡ Ç÷û »ùÇà ¾Ë·¹¸£°Õ ƯÀÌÀû IgE °ËÃâ¿¡ ÀÚÁÖ »ç¿ëµË´Ï´Ù. ¿¹¸¦ µé¾î 2018³â 7¿ù, Dynex Technologies´Â ZEUS Scientific°ú ¼¼°èÀÇ ÆÄÆ®³Ê½ÊÀ» ¹ßÇ¥Çß½À´Ï´Ù. 2021³â 8¿ù, Zeus Scientific Inc´Â Dynex Agility, Dynex DSX ¶Ç´Â Dynex DS2 Automated ELISA ½Ã½ºÅÛÀ» »ç¿ëÇÏ¿© ZEUS ELISA SARS-SoV-2 Àüü Ç×ü °Ë»ç ½Ã½ºÅÛÀ» ½ÇÇàÇÏ´Â FDA ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù. ELISA ºÐ¼®±â ½ÃÀå ¼ö¿ä ±ÞÁõÀº COVID-19 ±â°£ µ¿¾È ELISA °Ë»ç ŰƮ ÆÇ¸Å Áõ°¡¿Í ¼ö¿ä Áõ°¡¿¡ µû¸¥ °ÍÀ¸·Î ELISA ºÐ¼®±â ½ÃÀå È®´ë°¡ ¿¹»óµË´Ï´Ù.

ÃÖ±Ù µ¿Çâ

ELISA´Â Ç×ü Á¤·®¿¡ ÀÌ¿ëµÇ°í, ¶ÇÇÑ ¹é½Å °³¹ß Áß ¸é¿ª¿ø¼º Æò°¡¿¡µµ ÀÌ¿ëµË´Ï´Ù. µû¶ó¼­ ¹é½Å °³¹ßÀ» ÁÖµµÇÏ´Â ¿©·¯ ±â¾÷ÀÌ ELISA ºÐ¼®±â ¼ö¿ä¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ÁÖ¿ä Á¦¾à ȸ»çÀÎ Sanofi IncorporationÀº 2022³â 7¿ù¿¡ °³ÃÖµÈ 2022³â 2ºÐ±â °á»ê ¼³¸íȸ ÃֽŠÁ¤º¸¿¡ µû¸£¸é ÆÄÀÌÇÁ¶óÀο¡ 10°³ ¹é½Å È常¦ º¸À¯Çϰí ÀÖ½À´Ï´Ù.

»ç¿ë °¡´ÉÇÑ »ç¿ëÀÚ Á¤ÀÇ

TechSci Research´Â ÁÖ¾îÁø ½ÃÀå µ¥ÀÌÅ͸¦ »ç¿ëÇÏ¿© ±â¾÷ °íÀ¯ ¿ä±¸¿¡ ¸Â°Ô »ç¿ëÀÚ Á¤ÀǸ¦ Á¦°øÇÕ´Ï´Ù. º¸°í¼­´Â ´ÙÀ½À» »ç¿ëÀÚ Á¤ÀÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

±â¾÷ Á¤º¸

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ Àǰß

Á¦5Àå ELISA ºÐ¼®±â ½ÃÀå Àü¸Á.

Á¦6Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ELISA ºÐ¼®±â ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ ELISA ºÐ¼®±â ½ÃÀå Àü¸Á

Á¦8Àå ºÏ¹Ì ELISA ºÐ¼®±â ½ÃÀå Àü¸Á

Á¦9Àå ³²¹Ì ELISA ºÐ¼®±â ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ELISA ºÐ¼®±â ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå °æÀï ±¸µµ

Á¦14Àå Àü·« Á¦¾È

NJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

ELISA Analyzers Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as increasing demand for efficient tests for diagnosing the prevalence of infectious diseases and the growing need for technologically advanced instruments for disease detection, etc.

Enzyme-Linked Immunosorbent Assay (ELISA) is a laboratory test that is utilized for the detection of antibodies in the blood. The ELISA is based on the principle of antibody and antigen interaction and, thereby, is utilized in disease diagnosis. Analyzers are automated instruments that perform distinct steps of the assays and provide accurate and reproducible outcomes.

Moreover, the growing incidences of HIV, hepatitis, cancer, etc., and the rising involvement of ELISA analyzers in research and development involved in immunology and drug development are propelling the market demand for ELISA analyzers and thus supporting the market growth and are expected to propel it in the forecast period.

Rising Prevalence of Infectious Diseases

The growing prevalence of a disease among the population is propelling the market demand for ELISA analyzers. Rising infectious disease prevalence is growing worldwide, causing a huge health concern among people around the world. With this rapid increase in the account for infectious diseases such as cancer, hepatitis, HIV, etc., there is a surge observed in the direct demand for diagnosis and, thus, is adding to the market growth by propelling the market in the forecast period. For instance, Indian-based pharmaceutical company Biocon increased investment and spent USD 58.79 million in the year 2020.

Growing Demand for Technologically Advanced Tools in the Immunological Field

The accuracy and quick analysis of the biochemical and immunological parameters maintenance is a significant requirement for the analysis of immunological test results. Analyzers are designed in such a way as to ensure the ideal performance of the assays, such as maintaining sensitivity, lesser background noise, and quick reproducibility. Also, the ELISA analyzers, such as open system automated analyzers, are fitted with pre-programmed test menus and simple guides that aid in saving installation along with providing the user convenience. For instance, In May 2022, Molecular Devices, LLC., a leading provider of high-performance life science solutions, launched its automated work cells for ELISA workflows. The company introduced its five readymade new work cells for Enzyme-linked immunosorbent assay (ELISA) workflows, which provide automation qualities such as increased walkaway time and throughput, reducing the labor-intensive, repetitive work in large samples, and thereby is expected to surge the market growth in the coming years.

Rising Demand for Measuring Enzyme Activity

The measurement of enzyme activity, along with the detection of soluble proteins, cytokines, and other protein bodies, is fueling the ELISA analyzers' market demand. Additionally, the growing case of allergies has led to demand for diagnostic techniques such as ELISA. ELISA is a widely used diagnostic technique in the detection of food allergies. Furthermore, the indirect IgE-ELISA method is frequently used to detect allergen-specific IgE in serum samples due to its simplicity and low cost compared with other automated systems. For instance, In July 2018, Dynex Technologies announced its global Partnership with ZEUS Scientific. In August 2021, Zeus Scientific Inc obtained FDA authorization to use the Dynex Agility, Dynex DSX, or Dynex DS2 Automated ELISA Systems to run the ZEUS ELISA SARS-SoV-2 total antibody test system. The surge in market demand for ELISA analyzers is experienced with the increased sales and rising demand for ELISA test kits during the COVID-19 duration and is anticipated to bolster the ELISA analyzer market in the forecast period.

Recent Developments

ELISA is utilized to quantify antibody titers which are further utilized for the assessment of immunogenicity during vaccine development. Hence, several companies leading to their vaccine development have an increased demand for ELISA analyzers. For instance, a leading pharmaceutical company, Sanofi Incorporation, has 10 vaccine candidates in its pipeline, according to the latest updates at the Q2 2022 results meeting, which was held in July 2022.

Market Segmentation

ELISA Analyzers Market is segmented based on the type, mode, application, end-user, and region. Based on the type, the market is further segmented into optical filter ELISA analyzers and optical grating ELISA analyzers. Based on the mode, the market is segmented into automated ELISA analyzers and semi-automated analyzers. Based on application, the market is further fragmented into immunology, vaccine development, drug monitoring, and others. Depending on the End-user, the market is segmented into biotechnology companies, pharmaceutical companies, contract research organizations, and diagnostic laboratories. Based on the region, the Market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, Merck KGaA, F. Hoffmann-La Roche Ltd, Danaher Corporation, BioTech, Agilent Technologies, QIAGEN, and PerkinElmer Inc.., etc.., are some of the major players operating in the Global ELISA Analyzers Market.

Report Scope

In this report, Global ELISA Analyzers Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

ELISA Analyzers Market, By Type:

ELISA Analyzers Market, By Mode:

ELISA Analyzers Market, By Application:

ELISA Analyzers Market, By End User:

ELISA Analyzers Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in ELISA Analyzers Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global qELISA Analyzers Market Outlook.

6. Asia-Pacific ELISA Analyzers Market Outlook

7. Europe ELISA Analyzers Market Outlook

8. North America ELISA Analyzers Market Outlook

9. South America ELISA Analyzers Market Outlook

10. Middle East and Africa ELISA Analyzers Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Competitive Landscape

14. Strategic Recommendations

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â